The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lubner David Charles since 2014.
This trader's CIK number is 1572000.
At the time of last reporting, Lubner David Charles was the Officer of Point Biopharma Global Inc.. (stock ticker symbol PNT).
Also see all insider trading activities at Point Biopharma Global Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | RARX | 0 | $0 | 0 | $0 | 10,417 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | PNT | 3,600 | $24,660 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | TTPH | 0 | $0 | 49,500 | $2,089,265 | 39,500 | $158,490 |
| 2014 | TTPH | 0 | $0 | 32,474 | $434,720 | 88,391 | $145,226 |
1. Ra Pharmaceuticals, Inc. (RARX)
2. Point Biopharma Global Inc. (PNT)
3. Tetraphase Pharmaceuticals Inc (TTPH)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-02-01 | RARX | Option Ex | 10,417 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-11-23 | PNT | Buy | 3,600 | 6.85 | 24,660 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-08-14 | TTPH | Option Ex | 9,500 | 7.94 | 75,430 |
| 2015-08-14 | TTPH | Sale | 9,500 | 42.92 | 407,740 |
| 2015-07-14 | TTPH | Option Ex | 7,500 | 4.99 | 37,387 |
| 2015-07-14 | TTPH | Sale | 7,500 | 48.92 | 366,900 |
| 2015-06-15 | TTPH | Option Ex | 7,500 | 2.03 | 15,224 |
| 2015-06-15 | TTPH | Sale | 7,500 | 41.67 | 312,525 |
| 2015-06-12 | TTPH | Sale | 10,000 | 41.29 | 412,900 |
| 2015-05-14 | TTPH | Option Ex | 15,000 | 2.03 | 30,449 |
| 2015-05-14 | TTPH | Sale | 15,000 | 39.28 | 589,200 |
| 2014-06-17 | TTPH | Sale | 13,530 | 12.51 | 169,260 |
| 2014-03-06 | TTPH | Sale | 4,510 | 13.65 | 61,561 |
| 2014-02-12 | TTPH | Sale | 4,506 | 13.92 | 62,723 |
| 2014-02-07 | TTPH | Option Ex | 88,391 | 1.64 | 145,226 |
| 2014-02-07 | TTPH | Sale | 9,928 | 14.22 | 141,176 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lubner David Charles (Officer of Point Biopharma Global Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.